Data on Anticancer Agents Detailed by Researchers at Department of Chemistry (New Quinoxaline-piperazine-oxazole Conjugates: Synthesis, In Vitro Anticancer, In Silico Admet, and Molecular Docking Studies).

Předmět:	ANTINEOPLASTIC agents PIPERAZINE MOLECULAR docking RESEARCH personnel DRUG therapy HETEROCYCLIC chemistry
Zdroj:	Cancer Weekly; 2024, p288-288, 1p
Abstrakt:	Researchers at the Department of Chemistry in Telangana, India have synthesized new quinoxaline-piperazine-oxazole amide conjugates and tested their efficacy as anticancer agents. The compounds were characterized and tested for their antiproliferative activity against four different cancer cell lines. Some of the compounds were found to be more potent than the standard drug Erlotinib, and molecular docking studies suggested that all the compounds had stronger binding energies than Erlotinib. The research provides valuable insights into potential new anticancer agents. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu